Alcresta

Alcresta is a biopharmaceutical company based in Newton, MA, specializing in the development of enzyme-based products for individuals with rare diseases and serious medical conditions. Their innovative product, RELiZORB, is a digestive enzyme cartridge designed to assist patients who struggle with fat malabsorption during enteral feeding, providing them with optimal absorption and improved health outcomes.

With a focus on addressing fat malabsorption caused by exocrine pancreatic insufficiency, Alcresta's patented microbead enzyme technology, iLipase, breaks down fat for easy ingestion and digestion. Their products are particularly beneficial for patients with conditions such as cystic fibrosis, short bowel syndrome, pancreatitis, and digestive cancers, who often require enteral feeding for nutrition. Alcresta is committed to improving the lives of these individuals by providing them with enzyme products that enhance their ability to digest, absorb, and nourish their bodies effectively.

Generated from the website